Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Greenworks
301260
5
Tuoxin Pharmaceutical Group
301089
US Stock MarketDetailed Quotes
DNLI Denali Therapeutics
- 14.160
- +0.200+1.43%
Close May 15 16:00 ET
2.06BMarket Cap-5.30P/E (TTM)
14.205High13.555Low1.05MVolume14.000Open13.960Pre Close14.73MTurnover0.80%Turnover RatioLossP/E (Static)145.28MShares33.33052wk High1.83P/B1.85BFloat Cap10.57052wk Low--Dividend TTM130.90MShs Float93.940Historical High--Div YieldTTM4.66%Amplitude10.570Historical Low14.016Avg Price1Lot Size
Denali Therapeutics Key Stats
EPS
According to the latest financial report of Denali Therapeutics, the latest earnings per share (TTM) for the company is -0.78. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Denali Therapeutics's free cash flow? The latest report shows it as -136.55M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Denali Therapeutics shows that the company's current ratio is 9.56, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Denali Therapeutics, the quick ratio is 8.90, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Denali Therapeutics? The latest ROE figure is -11.31%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Denali Therapeutics, the total asset return on investment (ROA) is -10.05%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Denali Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Denali Therapeutics, the net profit margin is -7.84K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
Warren Buffett's Q1 Holdings Revealed: Has the Investment Trend Changed Drastically?
$Berkshire Hathaway-A (BRK.A.US)$ The first quarter Hold Positions report has been released, and the latest investment actions of the 'stock
Moomoo News Global
May 4 18:27
10 Unmissable Highlights of Berkshire's Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
